Neurotoxin Concerns, Controversy Escalate

Scientists are realizing that substances in the environment can have devastating effects on the human nervous system For decades, neuropathologist John Olney waged a one-man crusade to have "excitotoxins," chemicals in the brain that cause nerve cells to self-destruct, removed from foods. One of the worst, he argued, was glutamate, consumed by millions as the food flavoring monosodium glutamate. But nobody really paid much mind to Olney's concerns. The Food and Drug Administration (FDA) did no

Written byElizabeth Pennisi
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share


Scientists are realizing that substances in the environment can have devastating effects on the human nervous system
For decades, neuropathologist John Olney waged a one-man crusade to have "excitotoxins," chemicals in the brain that cause nerve cells to self-destruct, removed from foods. One of the worst, he argued, was glutamate, consumed by millions as the food flavoring monosodium glutamate. But nobody really paid much mind to Olney's concerns. The Food and Drug Administration (FDA) did not agree, and in 1970 judged the additive safe. So did, in that same year, a committee from the National Academy of Sciences (NAS).

But by 1980 scientists were beginning to realize that there were substances that warranted their attention. Lead in paint impaired learning. Epidemiological data revealed that Lucel-7, a substance used in making bathtubs, caused neurological damage in workers. In 1983, about 500 drug-users in San Francisco developed what appeared to be Parkinson's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies